このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

限局性筋層浸潤性膀胱がん患者の治療におけるアテゾリズマブ併用または非併用化学放射線療法

2026年11月17日 更新者:National Cancer Institute (NCI)

限局性筋層浸潤性膀胱癌におけるアテゾリズマブ併用または非併用化学放射線療法の第 III 相無作為化試験

This phase III trial studies how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized muscle invasive bladder cancer. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as gemcitabine, cisplatin, fluorouracil and mitomycin-C, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy with radiation therapy may kill more tumor cells. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving atezolizumab with radiation therapy and chemotherapy may work better in treating patients with localized muscle invasive bladder cancer compared to radiation therapy and chemotherapy without atezolizumab.

調査の概要

詳細な説明

PRIMARY OBJECTIVE:

I. To compare bladder intact event-free survival (BI-EFS) for concurrent chemoradiation therapy (CRT) with and without atezolizumab in localized muscle invasive bladder cancer (MIBC).

SECONDARY OBJECTIVES:

I. To compare overall survival between the two arms. II. To compare modified bladder intact event-free survival including cancer related death between arms.

III. To compare complete and partial pathologic response between arms at 3 months after completing chemoradiation therapy.

IV. To estimate metastases-free survival by arm. V. To compare the qualitative and quantitative adverse events from each arm. VI. To estimate the rate of non-muscle invasive bladder cancer recurrence by arm.

VII. To estimate the rate of salvage cystectomy and reasons for cystectomy by arm.

VIII. To compare mean patient-reported global quality of life (QOL) at week 54 using the European Organization for Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ)-Core (C)30 Global Health Status (GHS) subscale score between patients with localized muscle-invasive bladder cancer randomized to chemoradiation with versus (vs.) without atezolizumab.

TRANSLATIONAL MEDICINE OBJECTIVES:

I. To test the hypothesis that a panel of validated biomarkers of concurrent CRT involving nuclear MRE11, impaired deoxyribonucleic acid damage response (DDR) function and tumor subtyping will be prognostic for BI-EFS among patients receiving either concurrent CRT or chemoimmuno-radiotherapy (CIRT) of the primary tumor.

II. To test the hypothesis that tumor total mutation burden, neoantigen burden, infiltrating immune response, PD-L1 expression and T cell response are associated with augmented response after concurrent CIRT.

III. To bank urine specimens for future use.

PATIENT-REPORTED OUTCOMES (PROs) OBJECTIVES:

I. To compare mean patient-reported global QOL as measured by the EORTC QLQ-C30 Global Health Status subscale scores at week 54 between patients with localized muscle-invasive bladder cancer randomized to chemoradiation with vs. without atezolizumab. (Primary) II. To compare mean patient-reported bowel symptoms at each assessment time by arm using the Expanded Prostate Cancer Index Composite (EPIC) Bowel Assessment from the Expanded Prostate Index, the bladder-specific supplement to the QLQ-C30, the EORTC QLQ-Muscle Invasive Bladder Cancer (BLM30), the Physical Functioning subscale of the EORTC QLQ-C30, and overall health status using the EuroQol Five Dimension Five Level Scale (EQ-5D-5L). (Exploratory) III. To compare longitudinal change over time by arm in patient-reported global QOL using the EORTC QLQ-C30, the Bowel Domain of the Expanded Prostate Index (EPIC Bowel Assessment), the bladder-specific supplement to the QLQ-C30, the EORTC QLQ-BLM30, the Physical Functioning subscale of the EORTC QLQ-C30, and overall health status using the EQ-5D-5L. (Exploratory)

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients undergo radiation therapy (RT) (3 dimensional [D] CRT or intensity-modulated radiation therapy [IMRT]) daily Monday-Friday for up to 7-8 weeks. Patients also receive chemotherapy based on physician's choice of gemcitabine intravenously (IV) twice weekly for 6 weeks concurrent with RT, or cisplatin IV weekly for 6 weeks concurrent with RT, or fluorouracil IV on same days as doses 1-5 and 16-20 of radiation therapy and mitomycin IV on day 1 of radiation therapy in the absence of disease progression or unacceptable toxicity. Patients also undergo a transurethral resection of bladder tumor (TURBT) at randomization and week 18 as well as cystoscopy at randomization, at weeks 18, 30, 42, 54, then every 3 months through year 2, followed by every 6 months through year 5 and computed tomography (CT) or magnetic resonance imaging (MRI) at randomization, at weeks 18, 30, 42, 54, then every 6 months through year 2, followed by every 12 months through year 5.

ARM II: Patients undergo RT (3DCRT or IMRT) daily Monday-Friday for up to 7-8 weeks and receive chemotherapy based on physician's choice as in Arm I. Patients also receive atezolizumab IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 21 days for up to 9 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo a TURBT with bladder biopsy at randomization and week 18 as well as cystoscopy at randomization, at weeks 18, 30, 42, 54, then every 3 months through year 2, followed by every 6 months through year 5 and CT or MRI at randomization, at weeks 18, 30, 42, 54, then every 6 months through year 2, followed by every 12 months through year 5.

After completion of study treatment, patients are followed up every 3 months for 2 years, then every 6 months for 3 years.

研究の種類

介入

入学 (実際)

485

段階

  • フェーズ 3

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Arizona
      • Phoenix、Arizona、アメリカ、85054
        • Mayo Clinic Hospital in Arizona
      • Scottsdale、Arizona、アメリカ、85259
        • Mayo Clinic in Arizona
      • Tucson、Arizona、アメリカ、85719
        • Banner University Medical Center - Tucson
      • Tucson、Arizona、アメリカ、85719
        • University of Arizona Cancer Center-North Campus
    • California
      • Auburn、California、アメリカ、95602
        • Sutter Auburn Faith Hospital
      • Auburn、California、アメリカ、95603
        • Sutter Cancer Centers Radiation Oncology Services-Auburn
      • Berkeley、California、アメリカ、94704
        • Alta Bates Summit Medical Center-Herrick Campus
      • Carmichael、California、アメリカ、95608
        • Mercy San Juan Medical Center
      • Carmichael、California、アメリカ、95608
        • Mercy Cancer Center - Carmichael
      • Elk Grove、California、アメリカ、95758
        • Mercy Cancer Center - Elk Grove
      • La Jolla、California、アメリカ、92093
        • UC San Diego Moores Cancer Center
      • Los Angeles、California、アメリカ、90033
        • USC / Norris Comprehensive Cancer Center
      • Los Angeles、California、アメリカ、90048
        • Cedars-Sinai Medical Center
      • Los Angeles、California、アメリカ、90033
        • Los Angeles General Medical Center
      • Marysville、California、アメリカ、95901
        • Fremont - Rideout Cancer Center
      • Modesto、California、アメリカ、95355
        • Memorial Medical Center
      • Orange、California、アメリカ、92868
        • UC Irvine Health/Chao Family Comprehensive Cancer Center
      • Palo Alto、California、アメリカ、94301
        • Palo Alto Medical Foundation Health Care
      • Rocklin、California、アメリカ、95765
        • Mercy Cancer Center - Rocklin
      • Roseville、California、アメリカ、95661
        • Sutter Cancer Centers Radiation Oncology Services-Roseville
      • Roseville、California、アメリカ、95661
        • Sutter Roseville Medical Center
      • Sacramento、California、アメリカ、95816
        • Sutter Medical Center Sacramento
      • Sacramento、California、アメリカ、95817
        • University of California Davis Comprehensive Cancer Center
      • Sacramento、California、アメリカ、95816
        • Mercy Cancer Center - Sacramento
      • San Luis Obispo、California、アメリカ、93401
        • Pacific Central Coast Health Center-San Luis Obispo
      • Sunnyvale、California、アメリカ、94086
        • Palo Alto Medical Foundation-Sunnyvale
      • Woodland、California、アメリカ、95695
        • Woodland Memorial Hospital
    • Colorado
      • Aurora、Colorado、アメリカ、80045
        • UCHealth University of Colorado Hospital
      • Boulder、Colorado、アメリカ、80304
        • Rocky Mountain Cancer Centers-Boulder
      • Colorado Springs、Colorado、アメリカ、80909
        • UCHealth Memorial Hospital Central
      • Colorado Springs、Colorado、アメリカ、80920
        • Memorial Hospital North
      • Edwards、Colorado、アメリカ、81632
        • Shaw Cancer Center
      • Fort Collins、Colorado、アメリカ、80524
        • Poudre Valley Hospital
      • Fort Collins、Colorado、アメリカ、80528
        • Cancer Care and Hematology-Fort Collins
      • Greeley、Colorado、アメリカ、80631
        • UCHealth Greeley Hospital
      • Greeley、Colorado、アメリカ、80631
        • Banner North Colorado Medical Center
      • Loveland、Colorado、アメリカ、80538
        • Medical Center of the Rockies
      • Loveland、Colorado、アメリカ、80539
        • Banner North Colorado Medical Center - Loveland Campus
    • Connecticut
      • Greenwich、Connecticut、アメリカ、06830
        • Smilow Cancer Hospital Care Center at Greenwich
      • Guilford、Connecticut、アメリカ、06437
        • Smilow Cancer Hospital Care Center - Guilford
      • Hartford、Connecticut、アメリカ、06102
        • Hartford Hospital
      • Meriden、Connecticut、アメリカ、06451
        • Midstate Medical Center
      • New Britain、Connecticut、アメリカ、06050
        • The Hospital of Central Connecticut
      • New Haven、Connecticut、アメリカ、06520
        • Yale University
      • North Haven、Connecticut、アメリカ、06473
        • Yale-New Haven Hospital North Haven Medical Center
      • Trumbull、Connecticut、アメリカ、06611
        • Smilow Cancer Hospital Care Center-Trumbull
      • Waterford、Connecticut、アメリカ、06385
        • Smilow Cancer Hospital Care Center - Waterford
    • Delaware
      • Millville、Delaware、アメリカ、19967
        • Beebe South Coastal Health Campus
      • Newark、Delaware、アメリカ、19713
        • Helen F Graham Cancer Center
      • Newark、Delaware、アメリカ、19713
        • Medical Oncology Hematology Consultants PA
      • Rehoboth Beach、Delaware、アメリカ、19971
        • Beebe Health Campus
    • District of Columbia
      • Washington D.C.、District of Columbia、アメリカ、20016
        • Sibley Memorial Hospital
    • Florida
      • Aventura、Florida、アメリカ、33180
        • Mount Sinai Comprehensive Cancer Center at Aventura
      • Coral Gables、Florida、アメリカ、33146
        • UM Sylvester Comprehensive Cancer Center at Coral Gables
      • Deerfield Beach、Florida、アメリカ、33442
        • UM Sylvester Comprehensive Cancer Center at Deerfield Beach
      • Gainesville、Florida、アメリカ、32610
        • UF Health Cancer Institute - Gainesville
      • Miami、Florida、アメリカ、33136
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
      • Miami Beach、Florida、アメリカ、33140
        • Mount Sinai Medical Center
      • N. Venice、Florida、アメリカ、34275
        • Sarasota Memorial Hospital-Venice
      • Sarasota、Florida、アメリカ、34239
        • Sarasota Memorial Hospital
      • Sarasota、Florida、アメリカ、34232
        • Florida Cancer Specialists - Sarasota
      • Sarasota、Florida、アメリカ、34239
        • First Physicians Group - Urology Robotic and Minimally Invasive Surgery
      • Sarasota、Florida、アメリカ、34243
        • Sarasota Memorial Health Care Center at University Parkway
      • Sarasota、Florida、アメリカ、34239
        • Florida Cancer Specialists - Sarasota Downtown
      • Tampa、Florida、アメリカ、33612
        • Moffitt Cancer Center
    • Georgia
      • Atlanta、Georgia、アメリカ、30308
        • Emory University Hospital Midtown
      • Atlanta、Georgia、アメリカ、30322
        • Emory University Hospital/Winship Cancer Institute
      • Atlanta、Georgia、アメリカ、30342
        • Emory Saint Joseph's Hospital
      • Newnan、Georgia、アメリカ、30265
        • CTCA at Southeastern Regional Medical Center
    • Hawaii
      • Honolulu、Hawaii、アメリカ、96813
        • Queen's Medical Center
      • Honolulu、Hawaii、アメリカ、96817
        • The Cancer Center of Hawaii-Liliha
      • Honolulu、Hawaii、アメリカ、96813
        • Hawaii Cancer Care Inc - Waterfront Plaza
      • Honolulu、Hawaii、アメリカ、96813
        • Queen's Cancer Cenrer - POB I
      • Honolulu、Hawaii、アメリカ、96813
        • Straub Clinic and Hospital
      • Honolulu、Hawaii、アメリカ、96817
        • Queen's Cancer Center - Kuakini
      • ‘Aiea、Hawaii、アメリカ、96701
        • Hawaii Cancer Care - Westridge
      • ‘Aiea、Hawaii、アメリカ、96701
        • Pali Momi Medical Center
      • ‘Aiea、Hawaii、アメリカ、96701
        • The Cancer Center of Hawaii-Pali Momi
    • Illinois
      • Barrington、Illinois、アメリカ、60010
        • Advocate Good Shepherd Hospital
      • Bloomington、Illinois、アメリカ、61704
        • Illinois CancerCare-Bloomington
      • Canton、Illinois、アメリカ、61520
        • Illinois CancerCare-Canton
      • Carthage、Illinois、アメリカ、62321
        • Illinois CancerCare-Carthage
      • Chicago、Illinois、アメリカ、60611
        • Northwestern University
      • Chicago、Illinois、アメリカ、60657
        • Advocate Illinois Masonic Medical Center
      • Chicago、Illinois、アメリカ、60612
        • Rush MD Anderson Cancer Center
      • Crystal Lake、Illinois、アメリカ、60014
        • AMG Crystal Lake - Oncology
      • DeKalb、Illinois、アメリカ、60115
        • Northwestern Medicine Cancer Center Kishwaukee
      • Decatur、Illinois、アメリカ、62526
        • Decatur Memorial Hospital
      • Downers Grove、Illinois、アメリカ、60515
        • Advocate Good Samaritan Hospital
      • Effingham、Illinois、アメリカ、62401
        • Crossroads Cancer Center
      • Elgin、Illinois、アメリカ、60123
        • Advocate Sherman Hospital
      • Elmhurst、Illinois、アメリカ、60126
        • Elmhurst Memorial Hospital
      • Eureka、Illinois、アメリカ、61530
        • Illinois CancerCare-Eureka
      • Evanston、Illinois、アメリカ、60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Galesburg、Illinois、アメリカ、61401
        • Western Illinois Cancer Treatment Center
      • Galesburg、Illinois、アメリカ、61401
        • Illinois CancerCare-Galesburg
      • Geneva、Illinois、アメリカ、60134
        • Northwestern Medicine Cancer Center Delnor
      • Glenview、Illinois、アメリカ、60026
        • NorthShore University HealthSystem-Glenbrook Hospital
      • Hazel Crest、Illinois、アメリカ、60429
        • Advocate South Suburban Hospital
      • Highland Park、Illinois、アメリカ、60035
        • NorthShore University HealthSystem-Highland Park Hospital
      • Hines、Illinois、アメリカ、60141
        • Edward Hines Jr VA Hospital
      • Kewanee、Illinois、アメリカ、61443
        • Illinois CancerCare-Kewanee Clinic
      • Libertyville、Illinois、アメリカ、60048
        • Condell Memorial Hospital
      • Libertyville、Illinois、アメリカ、60048
        • AMG Libertyville - Oncology
      • Macomb、Illinois、アメリカ、61455
        • Illinois CancerCare-Macomb
      • Maywood、Illinois、アメリカ、60153
        • Loyola University Medical Center
      • Naperville、Illinois、アメリカ、60540
        • Edward Hospital/Cancer Center
      • Oak Lawn、Illinois、アメリカ、60453-2699
        • Advocate Christ Medical Center
      • Ottawa、Illinois、アメリカ、61350
        • Illinois CancerCare-Ottawa Clinic
      • Park Ridge、Illinois、アメリカ、60068
        • Advocate Lutheran General Hospital
      • Pekin、Illinois、アメリカ、61554
        • Illinois CancerCare-Pekin
      • Peoria、Illinois、アメリカ、61636
        • Methodist Medical Center of Illinois
      • Peoria、Illinois、アメリカ、61637
        • OSF Saint Francis Medical Center
      • Peoria、Illinois、アメリカ、61615
        • Illinois CancerCare-Peoria
      • Peru、Illinois、アメリカ、61354
        • Illinois CancerCare-Peru
      • Princeton、Illinois、アメリカ、61356
        • Illinois CancerCare-Princeton
      • Springfield、Illinois、アメリカ、62702
        • Springfield Clinic
      • Springfield、Illinois、アメリカ、62781
        • Springfield Memorial Hospital
      • Urbana、Illinois、アメリカ、61801
        • Carle Cancer Center
      • Warrenville、Illinois、アメリカ、60555
        • Northwestern Medicine Cancer Center Warrenville
      • Washington、Illinois、アメリカ、61571
        • Illinois CancerCare - Washington
    • Indiana
      • Indianapolis、Indiana、アメリカ、46219
        • Community Cancer Center East
      • Indianapolis、Indiana、アメリカ、46227
        • Community Cancer Center South
      • Indianapolis、Indiana、アメリカ、46256
        • Community Cancer Center North
      • Richmond、Indiana、アメリカ、47374
        • Reid Health
    • Iowa
      • Ames、Iowa、アメリカ、50010
        • Mary Greeley Medical Center
      • Ames、Iowa、アメリカ、50010
        • McFarland Clinic - Ames
      • Clive、Iowa、アメリカ、50325
        • Mercy Cancer Center-West Lakes
      • Clive、Iowa、アメリカ、50325
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
      • Creston、Iowa、アメリカ、50801
        • Greater Regional Medical Center
      • Des Moines、Iowa、アメリカ、50309
        • Iowa Methodist Medical Center
      • Des Moines、Iowa、アメリカ、50314
        • Mercy Medical Center - Des Moines
      • Des Moines、Iowa、アメリカ、50314
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
      • West Des Moines、Iowa、アメリカ、50266
        • Mercy Medical Center-West Lakes
    • Kansas
      • Kansas City、Kansas、アメリカ、66160
        • University of Kansas Cancer Center
      • Overland Park、Kansas、アメリカ、66210
        • University of Kansas Cancer Center-Overland Park
      • Westwood、Kansas、アメリカ、66205
        • University of Kansas Hospital-Westwood Cancer Center
      • Wichita、Kansas、アメリカ、67214
        • Ascension Via Christi Hospitals Wichita
    • Kentucky
      • Lexington、Kentucky、アメリカ、40536
        • University of Kentucky/Markey Cancer Center
      • Lexington、Kentucky、アメリカ、40503
        • Baptist Health Lexington
      • Louisville、Kentucky、アメリカ、40202
        • The James Graham Brown Cancer Center at University of Louisville
      • Louisville、Kentucky、アメリカ、40207
        • Baptist Health Louisville
    • Louisiana
      • Baton Rouge、Louisiana、アメリカ、70809
        • Louisiana Hematology Oncology Associates LLC
      • Baton Rouge、Louisiana、アメリカ、70809
        • Mary Bird Perkins Cancer Center
      • Metairie、Louisiana、アメリカ、70006
        • East Jefferson General Hospital
      • Metairie、Louisiana、アメリカ、70006
        • LSU Healthcare Network / Metairie Multi-Specialty Clinic
      • New Orleans、Louisiana、アメリカ、70112
        • University Medical Center New Orleans
    • Maine
      • Bath、Maine、アメリカ、04530
        • MaineHealth Coastal Cancer Treatment Center
      • Belfast、Maine、アメリカ、04915
        • MaineHealth Waldo Hospital
      • Biddeford、Maine、アメリカ、04005
        • MaineHealth Maine Medical Center - Biddeford
      • Norway、Maine、アメリカ、04268
        • MaineHealth Stephens Hospital
      • Portland、Maine、アメリカ、04102
        • MaineHealth Maine Medical Center - Portland
      • Rockport、Maine、アメリカ、04856
        • Penobscot Bay Medical Center
      • Sanford、Maine、アメリカ、04073
        • MaineHealth Cancer Care Center of York County
      • Sanford、Maine、アメリカ、04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • Scarborough、Maine、アメリカ、04074
        • MaineHealth Maine Medical Center- Scarborough
      • South Portland、Maine、アメリカ、04106
        • MaineHealth Cancer Care and IV Therapy - South Portland
    • Maryland
      • Baltimore、Maryland、アメリカ、21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
    • Massachusetts
      • Boston、Massachusetts、アメリカ、02215
        • Dana-Farber Cancer Institute
      • Boston、Massachusetts、アメリカ、02114
        • Massachusetts General Hospital Cancer Center
      • Lowell、Massachusetts、アメリカ、01854
        • Lowell General Hospital
    • Michigan
      • Ann Arbor、Michigan、アメリカ、48109
        • University of Michigan Rogel Cancer Center
      • Ann Arbor、Michigan、アメリカ、48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Battle Creek、Michigan、アメリカ、49017
        • Bronson Battle Creek
      • Brighton、Michigan、アメリカ、48116
        • University of Michigan - Brighton Center for Specialty Care
      • Brighton、Michigan、アメリカ、48114
        • Trinity Health Medical Center - Brighton
      • Canton、Michigan、アメリカ、48188
        • Trinity Health Medical Center - Canton
      • Chelsea、Michigan、アメリカ、48118
        • Chelsea Hospital
      • Clarkston、Michigan、アメリカ、48346
        • Michigan Healthcare Professionals Clarkston
      • Dearborn、Michigan、アメリカ、48124
        • Corewell Health Dearborn Hospital
      • Detroit、Michigan、アメリカ、48202
        • Henry Ford Hospital
      • Detroit、Michigan、アメリカ、48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit、Michigan、アメリカ、48236
        • Henry Ford Health Saint John Hospital
      • Farmington Hills、Michigan、アメリカ、48334
        • Weisberg Cancer Treatment Center
      • Farmington Hills、Michigan、アメリカ、48334
        • Michigan Healthcare Professionals Farmington
      • Farmington Hills、Michigan、アメリカ、48336
        • Corewell Health Farmington Hills Hospital
      • Kalamazoo、Michigan、アメリカ、49007
        • West Michigan Cancer Center
      • Lansing、Michigan、アメリカ、48912
        • University of Michigan Health - Sparrow Lansing
      • Livonia、Michigan、アメリカ、48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Macomb、Michigan、アメリカ、48044
        • Henry Ford Saint John Hospital - Macomb Medical
      • Madison Heights、Michigan、アメリカ、48071
        • Michigan Healthcare Professionals Madison Heights
      • Pontiac、Michigan、アメリカ、48341
        • Trinity Health Saint Joseph Mercy Oakland Hospital
      • Pontiac、Michigan、アメリカ、48341
        • Michigan Healthcare Professionals Pontiac
      • Royal Oak、Michigan、アメリカ、48073
        • Corewell Health William Beaumont University Hospital
      • Saginaw、Michigan、アメリカ、48601
        • MyMichigan Medical Center Saginaw
      • Traverse City、Michigan、アメリカ、49684
        • Munson Medical Center
      • Troy、Michigan、アメリカ、48098
        • Michigan Healthcare Professionals Troy
      • Troy、Michigan、アメリカ、48085
        • Corewell Health Beaumont Troy Hospital
      • Warren、Michigan、アメリカ、48093
        • Henry Ford Health Warren Hospital
      • West Bloomfield、Michigan、アメリカ、48322
        • Henry Ford West Bloomfield Hospital
      • Wyoming、Michigan、アメリカ、49519
        • University of Michigan Health - West
    • Minnesota
      • Bemidji、Minnesota、アメリカ、56601
        • Sanford Joe Lueken Cancer Center
      • Coon Rapids、Minnesota、アメリカ、55433
        • Mercy Hospital
      • Duluth、Minnesota、アメリカ、55805
        • Miller-Dwan Hospital
      • Edina、Minnesota、アメリカ、55435
        • Fairview Southdale Hospital
      • Fridley、Minnesota、アメリカ、55432
        • Unity Hospital
      • Monticello、Minnesota、アメリカ、55362
        • Monticello Cancer Center
      • Rochester、Minnesota、アメリカ、55905
        • Mayo Clinic in Rochester
      • Saint Cloud、Minnesota、アメリカ、56303
        • Coborn Cancer Center at Saint Cloud Hospital
      • Saint Louis Park、Minnesota、アメリカ、55416
        • Park Nicollet Clinic - Saint Louis Park
      • Saint Paul、Minnesota、アメリカ、55101
        • Regions Hospital
    • Missouri
      • Bonne Terre、Missouri、アメリカ、63628
        • Parkland Health Center-Bonne Terre
      • Cape Girardeau、Missouri、アメリカ、63703
        • Saint Francis Medical Center
      • City of Saint Peters、Missouri、アメリカ、63376
        • Siteman Cancer Center at Saint Peters Hospital
      • Creve Coeur、Missouri、アメリカ、63141
        • Siteman Cancer Center at West County Hospital
      • Kansas City、Missouri、アメリカ、64154
        • University of Kansas Cancer Center - North
      • Lee's Summit、Missouri、アメリカ、64064
        • University of Kansas Cancer Center - Lee's Summit
      • Saint Joseph、Missouri、アメリカ、64506
        • Heartland Regional Medical Center
      • Sainte Genevieve、Missouri、アメリカ、63670
        • Sainte Genevieve County Memorial Hospital
      • Springfield、Missouri、アメリカ、65807
        • CoxHealth South Hospital
      • St Louis、Missouri、アメリカ、63110
        • Washington University School of Medicine
      • St Louis、Missouri、アメリカ、63129
        • Siteman Cancer Center-South County
      • St Louis、Missouri、アメリカ、63131
        • Missouri Baptist Medical Center
      • St Louis、Missouri、アメリカ、63141
        • Mercy Hospital Saint Louis
      • St Louis、Missouri、アメリカ、63128
        • Mercy Hospital South
      • Sullivan、Missouri、アメリカ、63080
        • Missouri Baptist Sullivan Hospital
    • Montana
      • Billings、Montana、アメリカ、59101
        • Billings Clinic Cancer Center
      • Bozeman、Montana、アメリカ、59715
        • Bozeman Health Deaconess Hospital
      • Great Falls、Montana、アメリカ、59405
        • Benefis Sletten Cancer Institute
    • Nebraska
      • Bellevue、Nebraska、アメリカ、68123
        • Nebraska Medicine-Bellevue
      • Kearney、Nebraska、アメリカ、68847
        • CHI Health Good Samaritan
      • Omaha、Nebraska、アメリカ、68114
        • Nebraska Methodist Hospital
      • Omaha、Nebraska、アメリカ、68198
        • University of Nebraska Medical Center
      • Omaha、Nebraska、アメリカ、68118
        • Nebraska Medicine-Village Pointe
    • Nevada
      • Las Vegas、Nevada、アメリカ、89102
        • OptumCare Cancer Care at Charleston
      • Las Vegas、Nevada、アメリカ、89106
        • Radiation Oncology Centers of Nevada Central
      • Las Vegas、Nevada、アメリカ、89119
        • Radiation Oncology Centers of Nevada Southeast
      • Las Vegas、Nevada、アメリカ、89128
        • Comprehensive Cancer Centers of Nevada - Northwest
      • Las Vegas、Nevada、アメリカ、89144
        • Comprehensive Cancer Centers of Nevada - Town Center
      • Las Vegas、Nevada、アメリカ、89148
        • Comprehensive Cancer Centers of Nevada
      • Las Vegas、Nevada、アメリカ、89169
        • Comprehensive Cancer Centers of Nevada - Central Valley
      • Las Vegas、Nevada、アメリカ、89183
        • OptumCare Cancer Care at Fort Apache
      • Reno、Nevada、アメリカ、89502
        • Renown Regional Medical Center
    • New Hampshire
      • Lebanon、New Hampshire、アメリカ、03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
    • New Jersey
      • Basking Ridge、New Jersey、アメリカ、07920
        • Memorial Sloan Kettering Basking Ridge
      • Camden、New Jersey、アメリカ、08103
        • Cooper Hospital University Medical Center
      • Hackensack、New Jersey、アメリカ、07601
        • Hackensack University Medical Center
      • Middletown、New Jersey、アメリカ、07748
        • Memorial Sloan Kettering Monmouth
      • Montvale、New Jersey、アメリカ、07645
        • Memorial Sloan Kettering Bergen
      • Voorhees Township、New Jersey、アメリカ、08043
        • MD Anderson Cancer Center at Cooper-Voorhees
    • New York
      • Commack、New York、アメリカ、11725
        • Memorial Sloan Kettering Commack
      • Harrison、New York、アメリカ、10604
        • Memorial Sloan Kettering Westchester
      • Lake Success、New York、アメリカ、11042
        • Northwell Health/Center for Advanced Medicine
      • New York、New York、アメリカ、10065
        • Memorial Sloan Kettering Cancer Center
      • Rochester、New York、アメリカ、14642
        • University of Rochester
      • Rochester、New York、アメリカ、14620
        • Highland Hospital
      • Sleepy Hollow、New York、アメリカ、10591
        • Phelps Memorial Hospital Center
      • Stony Brook、New York、アメリカ、11794
        • Stony Brook University Medical Center
      • Syracuse、New York、アメリカ、13210
        • State University of New York Upstate Medical University
      • The Bronx、New York、アメリカ、10461
        • Montefiore Medical Center-Einstein Campus
      • The Bronx、New York、アメリカ、10467
        • Montefiore Medical Center - Moses Campus
      • The Bronx、New York、アメリカ、10461
        • Montefiore Medical Center-Weiler Hospital
      • Uniondale、New York、アメリカ、11553
        • Memorial Sloan Kettering Nassau
      • West Islip、New York、アメリカ、11795
        • Good Samaritan University Hospital
    • North Carolina
      • Hendersonville、North Carolina、アメリカ、28791
        • Margaret R Pardee Memorial Hospital
      • Kenansville、North Carolina、アメリカ、28349
        • ECU Health Oncology Kenansville
      • Kinston、North Carolina、アメリカ、28501
        • ECU Health Oncology Kinston
      • Richlands、North Carolina、アメリカ、28574
        • ECU Health Oncology Richlands
    • North Dakota
      • Bismarck、North Dakota、アメリカ、58501
        • Sanford Bismarck Medical Center
      • Fargo、North Dakota、アメリカ、58122
        • Sanford Roger Maris Cancer Center
      • Fargo、North Dakota、アメリカ、58122
        • Sanford Broadway Medical Center
    • Ohio
      • Cincinnati、Ohio、アメリカ、45219
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cleveland、Ohio、アメリカ、44109
        • MetroHealth Medical Center
      • Columbus、Ohio、アメリカ、43210
        • Ohio State University Comprehensive Cancer Center
      • Dayton、Ohio、アメリカ、45415
        • Dayton Physician LLC - Englewood
      • Kettering、Ohio、アメリカ、45429
        • Kettering Medical Center
      • Kettering、Ohio、アメリカ、45409
        • Greater Dayton Cancer Center
      • West Chester、Ohio、アメリカ、45069
        • University of Cincinnati Cancer Center-West Chester
    • Oklahoma
      • Lawton、Oklahoma、アメリカ、73505
        • Cancer Centers of Southwest Oklahoma Research
      • Oklahoma City、Oklahoma、アメリカ、73104
        • University of Oklahoma Health Sciences Center
      • Oklahoma City、Oklahoma、アメリカ、73120
        • Mercy Hospital Oklahoma City
    • Oregon
      • Portland、Oregon、アメリカ、97239
        • Oregon Health and Science University
    • Pennsylvania
      • Allentown、Pennsylvania、アメリカ、18103
        • Lehigh Valley Hospital-Cedar Crest
      • Altoona、Pennsylvania、アメリカ、16601
        • UPMC Altoona
      • Beaver、Pennsylvania、アメリカ、15009
        • UPMC-Heritage Valley Health System Beaver
      • Bethlehem、Pennsylvania、アメリカ、18017
        • Lehigh Valley Hospital - Muhlenberg
      • Carlisle、Pennsylvania、アメリカ、17015
        • Carlisle Regional Cancer Center
      • Chadds Ford、Pennsylvania、アメリカ、19317
        • Christiana Care Health System-Concord Health Center
      • Danville、Pennsylvania、アメリカ、17822
        • Geisinger Medical Center
      • Erie、Pennsylvania、アメリカ、16505
        • UPMC Hillman Cancer Center Erie
      • Farrell、Pennsylvania、アメリカ、16121
        • UPMC Cancer Center at UPMC Horizon
      • Greensburg、Pennsylvania、アメリカ、15601
        • UPMC Cancer Centers - Arnold Palmer Pavilion
      • Harrisburg、Pennsylvania、アメリカ、17109
        • UPMC Pinnacle Cancer Center/Community Osteopathic Campus
      • Hershey、Pennsylvania、アメリカ、17033-0850
        • Penn State Milton S Hershey Medical Center
      • Johnstown、Pennsylvania、アメリカ、15901
        • UPMC-Johnstown/John P. Murtha Regional Cancer Center
      • Lewisburg、Pennsylvania、アメリカ、17837
        • Geisinger Medical Oncology-Lewisburg
      • McKeesport、Pennsylvania、アメリカ、15132
        • UPMC Cancer Center at UPMC McKeesport
      • Mechanicsburg、Pennsylvania、アメリカ、17050
        • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
      • Monroeville、Pennsylvania、アメリカ、15146
        • UPMC Cancer Center - Monroeville
      • Moon Township、Pennsylvania、アメリカ、15108
        • UPMC Hillman Cancer Center in Coraopolis
      • N. Huntingdon、Pennsylvania、アメリカ、15642
        • Arnold Palmer Cancer Center Medical Oncology Norwin
      • New Castle、Pennsylvania、アメリカ、16105
        • UPMC Hillman Cancer Center - New Castle
      • Pittsburgh、Pennsylvania、アメリカ、15232
        • UPMC Hillman Cancer Center
      • Pittsburgh、Pennsylvania、アメリカ、15213
        • UPMC-Magee Womens Hospital
      • Pittsburgh、Pennsylvania、アメリカ、15232
        • UPMC-Shadyside Hospital
      • Pittsburgh、Pennsylvania、アメリカ、15215
        • UPMC-Saint Margaret
      • Pittsburgh、Pennsylvania、アメリカ、15237
        • UPMC-Passavant Hospital
      • Pittsburgh、Pennsylvania、アメリカ、15243
        • UPMC-Saint Clair Hospital Cancer Center
      • Seneca、Pennsylvania、アメリカ、16346
        • UPMC Cancer Center at UPMC Northwest
      • Uniontown、Pennsylvania、アメリカ、15401
        • UPMC Uniontown Hospital Radiation Oncology
      • Washington、Pennsylvania、アメリカ、15301
        • UPMC Washington Hospital Radiation Oncology
      • Wilkes-Barre、Pennsylvania、アメリカ、18711
        • Geisinger Wyoming Valley/Henry Cancer Center
      • York、Pennsylvania、アメリカ、17408
        • UPMC Memorial
    • South Carolina
      • Charleston、South Carolina、アメリカ、29425
        • Medical University of South Carolina
      • Greenville、South Carolina、アメリカ、29605
        • Prisma Health Cancer Institute - Faris
      • Greenville、South Carolina、アメリカ、29615
        • Prisma Health Cancer Institute - Eastside
      • Greer、South Carolina、アメリカ、29650
        • Prisma Health Cancer Institute - Greer
      • Greer、South Carolina、アメリカ、29651
        • Gibbs Cancer Center-Pelham
      • Myrtle Beach、South Carolina、アメリカ、29577
        • Carolina Regional Cancer Center
      • Spartanburg、South Carolina、アメリカ、29303
        • Spartanburg Medical Center
    • South Dakota
      • Sioux Falls、South Dakota、アメリカ、57117-5134
        • Sanford USD Medical Center - Sioux Falls
      • Sioux Falls、South Dakota、アメリカ、57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Nashville、Tennessee、アメリカ、37232
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Dallas、Texas、アメリカ、75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Galveston、Texas、アメリカ、77555-0565
        • University of Texas Medical Branch
      • Houston、Texas、アメリカ、77030
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
      • Houston、Texas、アメリカ、77030
        • Michael E DeBakey VA Medical Center
      • Richardson、Texas、アメリカ、75080
        • UT Southwestern Clinical Center at Richardson/Plano
    • Vermont
      • Saint Johnsbury、Vermont、アメリカ、05819
        • Dartmouth Cancer Center - North
    • Virginia
      • Fishersville、Virginia、アメリカ、22939
        • Augusta Health Center for Cancer and Blood Disorders
    • Washington
      • Auburn、Washington、アメリカ、98001
        • MultiCare Auburn Medical Center
      • Gig Harbor、Washington、アメリカ、98335
        • MultiCare Gig Harbor Medical Park
      • Kirkland、Washington、アメリカ、98034
        • FHCC at EvergreenHealth
      • Puyallup、Washington、アメリカ、98372
        • MultiCare Good Samaritan Hospital
      • Renton、Washington、アメリカ、98055
        • Valley Medical Center
      • Seattle、Washington、アメリカ、98195
        • University of Washington Medical Center - Montlake
      • Seattle、Washington、アメリカ、98109
        • Fred Hutchinson Cancer Center
      • Silverdale、Washington、アメリカ、98383
        • Saint Joseph Medical Center Hematology and Oncology - Silverdale
      • Tacoma、Washington、アメリカ、98405
        • MultiCare Tacoma General Hospital
    • West Virginia
      • Morgantown、West Virginia、アメリカ、26506
        • West Virginia University Healthcare
    • Wisconsin
      • Antigo、Wisconsin、アメリカ、54409
        • Aspirus Cancer Care-Antigo-Volm Cancer Center
      • Appleton、Wisconsin、アメリカ、54915
        • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
      • Ashland、Wisconsin、アメリカ、54806
        • Northwest Wisconsin Cancer Center
      • Burlington、Wisconsin、アメリカ、53105
        • Aurora Cancer Care-Southern Lakes VLCC
      • Eau Claire、Wisconsin、アメリカ、54701
        • Marshfield Medical Center-EC Cancer Center
      • Eau Claire、Wisconsin、アメリカ、54701
        • Mayo Clinic Health System-Eau Claire Clinic
      • Germantown、Wisconsin、アメリカ、53022
        • Aurora Health Care Germantown Health Center
      • Grafton、Wisconsin、アメリカ、53024
        • Aurora Cancer Care-Grafton
      • Green Bay、Wisconsin、アメリカ、54311
        • Aurora BayCare Medical Center
      • Green Bay、Wisconsin、アメリカ、54301
        • Bellin Memorial Hospital
      • Kenosha、Wisconsin、アメリカ、53142
        • Aurora Cancer Care-Kenosha South
      • La Crosse、Wisconsin、アメリカ、54601
        • Mayo Clinic Health System-Franciscan Healthcare
      • Marinette、Wisconsin、アメリカ、54143
        • Aurora Bay Area Medical Group-Marinette
      • Marshfield、Wisconsin、アメリカ、54449
        • Marshfield Medical Center-Marshfield
      • Medford、Wisconsin、アメリカ、54451
        • Aspirus Medford Hospital
      • Milwaukee、Wisconsin、アメリカ、53209
        • Aurora Cancer Care-Milwaukee
      • Milwaukee、Wisconsin、アメリカ、53215
        • Aurora Saint Luke's Medical Center
      • Milwaukee、Wisconsin、アメリカ、53233
        • Aurora Sinai Medical Center
      • Minocqua、Wisconsin、アメリカ、54548
        • Marshfield Medical Center - Minocqua
      • New Richmond、Wisconsin、アメリカ、54017
        • Cancer Center of Western Wisconsin
      • Oshkosh、Wisconsin、アメリカ、54904
        • Vince Lombardi Cancer Clinic - Oshkosh
      • Oshkosh、Wisconsin、アメリカ、54904
        • Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
      • Racine、Wisconsin、アメリカ、53406
        • Aurora Cancer Care-Racine
      • Racine、Wisconsin、アメリカ、53405
        • Ascension All Saints Hospital-Spring Street-Racine
      • Rice Lake、Wisconsin、アメリカ、54868
        • Marshfield Medical Center-Rice Lake
      • Sheboygan、Wisconsin、アメリカ、53081
        • Vince Lombardi Cancer Clinic-Sheboygan
      • Stevens Point、Wisconsin、アメリカ、54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Stevens Point、Wisconsin、アメリカ、54481
        • Aspirus Cancer Care - Stevens Point
      • Summit、Wisconsin、アメリカ、53066
        • Aurora Medical Center in Summit
      • Two Rivers、Wisconsin、アメリカ、54241
        • Vince Lombardi Cancer Clinic-Two Rivers
      • Wausau、Wisconsin、アメリカ、54401
        • Aspirus Cancer Care-Wausau
      • Wauwatosa、Wisconsin、アメリカ、53226
        • Aurora Cancer Care-Milwaukee West
      • West Allis、Wisconsin、アメリカ、53227
        • Aurora West Allis Medical Center
      • Weston、Wisconsin、アメリカ、54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids、Wisconsin、アメリカ、54494
        • Aspirus Cancer Care - Wisconsin Rapids

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • STEP 1 REGISTRATION: If this will be the first patient from a registering site to receive a given RT modality (3DCRT vs. IMRT), the site must first submit pre-RT planning documents within 3 days of Step 1 registration and receive approval from Imaging and Radiation Oncology Core (IROC) before randomizing the patient to Step 2. If this will not be the first patient to receive a specific RT modality, the patient should be immediately randomized to Step 2 on the same day.

  • STEP 2 RANDOMIZATION: If patient required review of pre-RT planning, randomization must occur within 14 days of initial registration.

  • Patients must have histologically proven, T2-T4a N0M0 urothelial carcinoma of the bladder within 120 days prior to randomization and no intervening treatment between the histologic proof and randomization. Patients with mixed urothelial carcinoma will be eligible for the trial, but the presence of small cell carcinoma will make a patient ineligible. Patients with lymph nodes >= 1.0 cm in shortest cross-sectional diameter on imaging (computed tomography [CT]/magnetic resonance imaging [MRI] of abdomen and pelvis) must have a biopsy of the enlarged lymph node showing no tumor involvement within 70 days prior to randomization. These patients may be suitable for neoadjuvant chemotherapy and radical cystectomy and are eligible for this trial if they seek out a bladder sparing treatment strategy, however patients who have received prior systemic chemotherapy for bladder cancer are not eligible for the trial.

  • Patients must undergo a transurethral resection of bladder tumor (TURBT) within 70 days prior to randomization. In a situation where a patient is referred from outside to the enrolling institution, patient must have a repeat office cystoscopy by the urologist who will be following the patient on the clinical trial to assess the adequacy of the prior TURBT. This cystoscopy can be performed in urologist office without general anesthesia. Patient may then undergo repeat TURBT if deemed necessary as standard of care by the treating urologist. Patients may have either completely or partially resected tumors as long as the treating urologist attempted maximal resection. Patient must not have T4b disease

  • Patients must undergo radiological staging within 70 days prior to randomization. Imaging of chest, abdomen, and pelvis must be performed using CT or MRI. Patients must not have evidence of T4bN1-3 disease. Eligibility is based on the local radiology report.

  • Patients with hydronephrosis are eligible if they have unilateral hydronephrosis and kidney function meets criteria specified.

  • Patients must not have had urothelial carcinoma or histological variant at any site outside of the urinary bladder within the previous 24 months except Ta/T1/carcinoma in situ (CIS) of the upper urinary tract including renal pelvis and ureter if the patient had undergone complete nephroureterectomy.

  • Patients must not have diffuse CIS based on cystoscopy and biopsy.

  • Patient must be planning to receive one of the protocol specified chemotherapy regimens.

  • All adverse events associated with any prior surgery and intravesical therapy must have resolved to Common Terminology Criteria for Adverse Events (CTCAE) grade =< 2 prior to randomization.

  • Patient must not have received any systemic chemotherapy for their bladder cancer.

  • Patient must not have had prior pelvic radiation.

  • Patients must not have received prior treatment for muscle invasive bladder cancer including neoadjuvant chemotherapy for the current tumor.

  • Patients must not have received any systemic therapy (including, but not limited to, interferon alfa-2b, high dose IL-2, pegylated interferon [PEG-IFN], anti-PD-1, anti-PD-L1), for non-muscle invasive bladder cancer. Prior intravesical bacillus Calmette-Guerin (BCG), interferon, and intravesical chemotherapy are allowed.

  • Patients must not have received any of the following prohibited therapies within 28 days prior to randomization or be planning to receive any of the following prohibited therapies during protocol treatment:

    • Anti-cancer systemic chemotherapy or biological therapy not specified in the protocol.
    • Immunotherapy not specified in this protocol.
    • Systemic or intravesical use of any non-study anti-cancer agent (investigational or non-investigational).
    • Investigational agents other than atezolizumab.
    • Live vaccines: Examples of live vaccines include, but are not limited to, the following: measles, mumps, rubella, chicken pox, shingles, yellow fever, rabies, BCG, and typhoid (oral) vaccine. Seasonal influenza vaccines for injection are generally killed virus vaccines and are allowed; however, intranasal influenza vaccines (e.g. Flu-Mist®) are live attenuated vaccines, and are not allowed. Prior administration of intravesical BCG is allowed.
    • Glucocorticoids for any purpose other than to modulate symptoms from an event of suspected immunologic etiology. The use of physiologic doses of corticosteroids (defined as 10 mg prednisone) are acceptable, however site investigators should consult with the study chair for any dose higher than 10 mg prednisone. Dexamethasone 4 mg IV with chemotherapy to prevent nausea is allowed.
    • RANKL infusion: Concurrent denosumab (which binds the cytokine RANKL) for any known indication is prohibited due to interaction with study medication.
  • Patients must not have a major surgical procedure within 28 days prior to randomization. If patient had any surgical procedure then they should have recovered to full presurgical performance status and surgical adverse events should have resolved to grade =< 2. TURBT is not considered a major surgical procedure.

  • Patients must not have received treatment with systemic immunosuppressive medications (including, but not limited to, prednisone, cyclophosphamide, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis factor [anti-TNF] agents) within 14 days prior to randomization. Exceptions:

    • Patients may have received acute, low dose, systemic immunosuppressant medications (e.g., a one-time dose of dexamethasone for nausea).
    • The use of inhaled corticosteroids and mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed. Physiological doses equivalent of 10 mg prednisone daily are allowed. Short term steroids given as antiemetic therapy, e.g. 4 mg dexamethasone or equivalent once a week, is allowed.
  • Patients must not have received a live, attenuated vaccine within 4 weeks prior to randomization or anticipate that such a live, attenuated vaccine will be required while on protocol treatment and up to 5 months after the last dose of protocol treatment.

    • Inactivated influenza vaccination should be given during influenza season only (approximately October to March). Patients must not receive live, attenuated influenza vaccine within 4 weeks prior to randomization or while on protocol treatment and up to 5 months after the last dose of protocol treatment.
  • Patients must not have undergone prior allogeneic bone marrow transplantation or prior solid organ transplantation.

  • Patients must be >= 18 years of age

  • Patient may or may not be radical cystectomy candidates.

  • Absolute neutrophil count (ANC) >= 1,500/microliter (mcL) (within 28 days prior to randomization).

  • Platelets >= 100,000/mcL (within 28 days prior to randomization).

  • Hemoglobin >= 9 g/dL (within 28 days prior to randomization).

  • Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (except patients with Gilbert's syndrome, who must have a total bilirubin < 3.0 mg/dL) (within 28 days prior to randomization).

  • Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) < 2.5 x IULN (within 28 days prior to randomization).

  • Patients must not have clinically significant liver disease that precludes patient from treatment regimens prescribed on the study (including, but not limited to, active viral, alcoholic or other autoimmune hepatitis, cirrhosis or inherited liver disease).

  • Patients must have adequate renal function as evidenced by calculated creatinine clearance >= 25 mL/min. The creatinine used to calculate the clearance result must have been obtained within 28 days prior to randomization.

  • Patients must have Zubrod performance status =< 2.

  • Patients must have a baseline electrocardiography (ECG) performed within 30 days prior to randomization.

  • Patient must not have history of idiopathic pulmonary fibrosis, pneumonitis (including drug induced), organizing pneumonia (i.e., bronchiolitis obliterans, cryptogenic organizing pneumonia, etc.), or evidence of active pneumonitis.

  • Patients must not have an active infection requiring oral or IV antibiotics within 14 days prior to randomization. Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are not eligible. If patient develops urinary tract infection after TURBT they must have recovered from the infection prior to registration.

  • Patients must not have active autoimmune disease that has required systemic treatment in past two years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs). Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not considered a form of systemic treatment. Autoimmune diseases include, but are not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, Graves' disease treated with methimazole or glomerulonephritis.

  • Patient must not have a history of active tuberculosis.

  • If patient has a known history of hepatitis B virus (HBV) or hepatitis C virus (HCV), they must meet the following criteria within 28 days prior to randomization.

    • Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B surface antigen [HBsAg] test and a positive anti-HBc [antibody to hepatitis B core antigen] antibody test) are eligible.
    • Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase chain reaction (PCR) is negative for HCV ribonucleic acid (RNA).
  • Patients who are known to be positive for human immunodeficiency virus (HIV) are eligible only if they have all of the following:

    • A stable regimen of highly active anti-retroviral therapy (HAART)
    • No requirement for concurrent antibiotics or antifungal agents for the prevention of opportunistic infections
    • A CD4 count above 250 cells/mcL and an undetectable HIV viral load on standard PCR-based tests within 28 days prior to randomization.
  • No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated Stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for two years. Patients with localized prostate cancer who are being followed by an active surveillance program are also eligible.

  • Female patients of childbearing potential must have a serum pregnancy test prior to randomization. Patients must not be pregnant or nursing due to the potential teratogenic side effects of the protocol treatment. Women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of protocol treatment, and for 5 months (150 days) after the last dose of all study drugs. A woman is considered to be of "reproductive potential" if she has had a menses at any time in the preceding 12 consecutive months.

  • Patients must not be known to be allergic to Chinese hamster egg or ovary cell products and must not have any known major allergic reactions to any study drug.

  • Patients must be offered the opportunity to participate in specimen banking for future studies.

  • Patients who can complete Patient-Reported Outcome instruments in English or Spanish must agree to complete the EORTC QLQ-C30, the EORTC QLQ-BLM30, the EPIC Bowel Assessment, and the EQ-5D-5L per protocol schedule of assessment.

  • As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Arm I (RT, chemotherapy)

Patients undergo RT (3DCRT or IMRT) daily Monday-Friday for up to 7-8 weeks. Patients also receive chemotherapy based on physician's choice of gemcitabine IV twice weekly for 6 weeks concurrent with RT, or cisplatin IV weekly for 6 weeks concurrent with RT, or fluorouracil IV on same days as doses 1-5 and 16-20 of radiation therapy and mitomycin IV on day 1 of radiation therapy in the absence of disease progression or unacceptable toxicity. Patients also undergo a TURBT with bladder biopsy at randomization and week 18 as well as cystoscopy at randomization, at weeks 18, 30, 42, 54, then every 3 months through year 2, followed by every 6months through year 5 and CT or MRI at randomization, at weeks 18, 30, 42, 54, then every 6 months through year 2, followed by every 12 months through year 5.

Ancillary studies

他の名前:
  • 生活の質の評価

Given IV

他の名前:
  • CDDP
  • シスジアミンジクロリド白金
  • シスマプラット
  • シスプラチナム
  • ネオプラチン
  • プラチノール
  • アビプラチン
  • ブラストレム
  • ブリプラチン
  • シス-ジアミン-ジクロロ白金
  • シス-ジアミンジクロロ 白金(II)
  • シスジアミンジクロロ白金
  • Cis-ジクロロアミン プラチナ (II)
  • シス白金ジアミンジクロリド
  • シスプラチナ
  • シスプラチナⅡ
  • シスプラチナⅡジアミンジクロリド
  • シスプラチル
  • シトプラチノ
  • シトシン
  • シスプラティナ
  • DDP
  • レーダープラチン
  • メタプラチン
  • ペイロンの塩化物
  • ペロンの塩
  • プラシス
  • プラススティル
  • プラタミン
  • プラチブラスチン
  • プラチブラスチン-S
  • プラティネックス
  • プラチノール-AQ
  • プラチノール-AQ VHA プラス
  • プラチノキサン
  • 白金
  • 白金ジアミノ二塩化物
  • プラティラン
  • プラティスチン
  • プラトシン

Given IV

他の名前:
  • 5-フルラシル
  • フルラシル
  • 5 フルオロウラシル
  • 5 フルオロウラシルム
  • 5福
  • 5-フルオロ-2,4(1H, 3H)-ピリミジンジオン
  • 5-フルオロウラシル
  • 五府
  • 5FU
  • アキュサイト
  • カラック
  • フルオロウラシル
  • フルウラシル
  • フルブラスチン
  • フルラセジル
  • フリル
  • フルロブラスチン
  • リボフルオール
  • ロ2-9757
  • Ro-2-9757

Given IV

他の名前:
  • dFdCyd
  • DFDC
  • ジフルオロデオキシシチジン

Undergo a cystoscopy

他の名前:
  • CS

Given IV

他の名前:
  • ムタマイシン
  • アメチシン
  • ジェルミート
  • 水戸
  • 水戸C
  • 水戸メダック
  • マイトシン
  • マイトシン-C
  • ミトレム
  • マイトマイシン C
  • マイトマイシン-C
  • マイトマイシン-X
  • マイトマイシンC
  • ミトソル
  • ミトザイトレックス
  • NCI-C04706
  • マイトマイシン腎盂皮質

Ancillary studies

Undergo a bladder biopsy

他の名前:
  • 膀胱生検

Undergo CT or MRI

他の名前:
  • CT
  • 猫
  • CATスキャン
  • コンピューター断層撮影
  • コンピュータ化されたアキシャルトモグラフィー
  • CTスキャン
  • トモグラフィー
  • コンピューター断層撮影 (手順)
  • コンピューター断層撮影 (CT) スキャン
  • 診断CATスキャン
  • 診断CATスキャンサービスタイプ

Undergo CT or MRI

他の名前:
  • MRI
  • 磁気共鳴
  • 磁気共鳴画像スキャン
  • 医用画像、磁気共鳴 / 核磁気共鳴
  • 氏
  • MRイメージング
  • MRI スキャン
  • NMRイメージング
  • NMRI
  • 核磁気共鳴イメージング
  • 磁気共鳴画像法 (MRI)
  • sMRI
  • 磁気共鳴画像法(手順)
  • 構造MRI

Undergo 3DCRT or IMRT

他の名前:
  • がん放射線治療
  • ENERGY_TYPE
  • 照射する
  • 照射された
  • 照射
  • 放射線
  • 放射線治療、NOS
  • 放射線治療学
  • 放射線治療
  • RT
  • 治療、放射線
  • エネルギーの種類

Undergo a TURBT

他の名前:
  • 経尿道的切除(TURBT)
  • ターン
実験的:Arm II (RT, chemotherapy, atezolizumab)

Patients undergo RT (3DCRT or IMRT) daily Monday-Friday for up to 7-8 weeks and receive chemotherapy based on physician's choice as in Arm I. Patients also receive atezolizumab IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 21 days for up to 9 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo a TURBT with bladder biopsy at randomization and week 18 as well as cystoscopy at randomization, at weeks 18, 30, 42, 54, then every 3 months through year 2, followed by every 6months through year 5 and CT or MRI at randomization, at weeks 18, 30, 42, 54, then every 6 months through year 2, followed by every 12 months through year 5.

Ancillary studies

他の名前:
  • 生活の質の評価

Given IV

他の名前:
  • CDDP
  • シスジアミンジクロリド白金
  • シスマプラット
  • シスプラチナム
  • ネオプラチン
  • プラチノール
  • アビプラチン
  • ブラストレム
  • ブリプラチン
  • シス-ジアミン-ジクロロ白金
  • シス-ジアミンジクロロ 白金(II)
  • シスジアミンジクロロ白金
  • Cis-ジクロロアミン プラチナ (II)
  • シス白金ジアミンジクロリド
  • シスプラチナ
  • シスプラチナⅡ
  • シスプラチナⅡジアミンジクロリド
  • シスプラチル
  • シトプラチノ
  • シトシン
  • シスプラティナ
  • DDP
  • レーダープラチン
  • メタプラチン
  • ペイロンの塩化物
  • ペロンの塩
  • プラシス
  • プラススティル
  • プラタミン
  • プラチブラスチン
  • プラチブラスチン-S
  • プラティネックス
  • プラチノール-AQ
  • プラチノール-AQ VHA プラス
  • プラチノキサン
  • 白金
  • 白金ジアミノ二塩化物
  • プラティラン
  • プラティスチン
  • プラトシン

Given IV

他の名前:
  • 5-フルラシル
  • フルラシル
  • 5 フルオロウラシル
  • 5 フルオロウラシルム
  • 5福
  • 5-フルオロ-2,4(1H, 3H)-ピリミジンジオン
  • 5-フルオロウラシル
  • 五府
  • 5FU
  • アキュサイト
  • カラック
  • フルオロウラシル
  • フルウラシル
  • フルブラスチン
  • フルラセジル
  • フリル
  • フルロブラスチン
  • リボフルオール
  • ロ2-9757
  • Ro-2-9757

Given IV

他の名前:
  • dFdCyd
  • DFDC
  • ジフルオロデオキシシチジン

Given IV

他の名前:
  • テセントリク
  • MPDL3280A
  • RO5541267
  • RG7446
  • MPDL 328OA
  • MPDL-3280A
  • MPDL328OA
  • RG-7446
  • RO 5541267
  • RO-5541267

Undergo a cystoscopy

他の名前:
  • CS

Given IV

他の名前:
  • ムタマイシン
  • アメチシン
  • ジェルミート
  • 水戸
  • 水戸C
  • 水戸メダック
  • マイトシン
  • マイトシン-C
  • ミトレム
  • マイトマイシン C
  • マイトマイシン-C
  • マイトマイシン-X
  • マイトマイシンC
  • ミトソル
  • ミトザイトレックス
  • NCI-C04706
  • マイトマイシン腎盂皮質

Ancillary studies

Undergo a bladder biopsy

他の名前:
  • 膀胱生検

Undergo CT or MRI

他の名前:
  • CT
  • 猫
  • CATスキャン
  • コンピューター断層撮影
  • コンピュータ化されたアキシャルトモグラフィー
  • CTスキャン
  • トモグラフィー
  • コンピューター断層撮影 (手順)
  • コンピューター断層撮影 (CT) スキャン
  • 診断CATスキャン
  • 診断CATスキャンサービスタイプ

Undergo CT or MRI

他の名前:
  • MRI
  • 磁気共鳴
  • 磁気共鳴画像スキャン
  • 医用画像、磁気共鳴 / 核磁気共鳴
  • 氏
  • MRイメージング
  • MRI スキャン
  • NMRイメージング
  • NMRI
  • 核磁気共鳴イメージング
  • 磁気共鳴画像法 (MRI)
  • sMRI
  • 磁気共鳴画像法(手順)
  • 構造MRI

Undergo 3DCRT or IMRT

他の名前:
  • がん放射線治療
  • ENERGY_TYPE
  • 照射する
  • 照射された
  • 照射
  • 放射線
  • 放射線治療、NOS
  • 放射線治療学
  • 放射線治療
  • RT
  • 治療、放射線
  • エネルギーの種類

Undergo a TURBT

他の名前:
  • 経尿道的切除(TURBT)
  • ターン

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Bladder intact event-free survival (BI-EFS)
時間枠:From the date of randomization to the first documentation of a BI-EFS event, assessed up to 5 years

At each time point, futility will be evaluated, and in the latter two analyses, efficacy will also be evaluated as specified. The final BI-EFS intent-to-treat analysis will be conducted using a stratified logrank test stratifying on stratification factors, and testing treatment at the one-sided significance level of 0.022 to account for multiple interim testing. The hazard ratio (HR) will be estimated using a stratified Cox proportional hazards model and the 95% confidence interval (CI) for the HR will be provided. Results from an unstratified analysis will also be provided. Kaplan-Meier methodology will be used to estimate the median BI-EFS for each treatment arm.

From the date of randomization to the first documentation of a BI-EFS event, assessed up to 5 years

二次結果の測定

結果測定
メジャーの説明
時間枠
がん特異的生存率
時間枠:無作為化日から膀胱癌による死亡日まで、最大5年間評価
無作為化日から膀胱癌による死亡日まで、最大5年間評価
Overall survival (OS)
時間枠:From date of randomization to death from any cause, assessed up to 5 years

Will be estimated using Kaplan-Meier methodology for each treatment arm. Will be analyzed using a similar method as for BI-EFS.

From date of randomization to death from any cause, assessed up to 5 years
Modified bladder intact event-free survival (mBI-EFS)
時間枠:From date of randomization to the first documentation of a mBI-EFS event, assessed within 90 days

Analysis of modified BI-EFS, i.e., a sensitivity analysis of BI-EFS, where bladder cancer event is defined as histologically proven presence of muscle invasive bladder cancer, clinical evidence of nodal or metastatic disease, radical cystectomy, or death within 90 days of receiving protocol specified treatment, will also be conducted.

From date of randomization to the first documentation of a mBI-EFS event, assessed within 90 days
Biopsy response
時間枠:At 18 weeks

The Cochran-Mantel-Haenszel statistic will be used with modified ridit scores to evaluate the biopsy outcomes of complete response versus (vs.) down-staging vs. no response for the two treatment arms.

At 18 weeks
Complete response duration
時間枠:From the date of the biopsy documenting the complete response to the time of muscle invasive recurrence, local progression, evidence of metastatic disease or death due to any cause, assessed at 18 weeks

For the subset of patients who achieve a complete response during the week 18 biopsy window, complete response duration is defined from the date of the biopsy documenting the complete response to the time of muscle invasive recurrence, local progression, evidence of metastatic disease or death due to any cause. Will be analyzed using a similar method as for BI-EFS.

From the date of the biopsy documenting the complete response to the time of muscle invasive recurrence, local progression, evidence of metastatic disease or death due to any cause, assessed at 18 weeks
Progression-free survival
時間枠:From date of randomization to first radiologic or histologic evidence of local progression, nodal or distant metastasis, or death due to any cause, assessed up to 5 years

Will be estimated using Kaplan-Meier methodology for each treatment arm. Will be analyzed using a similar method as for BI-EFS.

From date of randomization to first radiologic or histologic evidence of local progression, nodal or distant metastasis, or death due to any cause, assessed up to 5 years
Metastasis-free survival
時間枠:From date of randomization to first radiologic or histologic evidence of metastatic disease or death due to any cause, assessed up to 5 years

Will be estimated using Kaplan-Meier methodology for each treatment arm. Will be analyzed using a similar method as for BI-EFS.

From date of randomization to first radiologic or histologic evidence of metastatic disease or death due to any cause, assessed up to 5 years
Quality of life
時間枠:Baseline up to 5 years

Assessed with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life (QLQ)-C30. Will be examined using linear mixed models with patient considered as the random effect. The baseline physical function score and the stratification factors will be included in the regression model as adjustment covariates.

Baseline up to 5 years

その他の成果指標

結果測定
メジャーの説明
時間枠
Treatment interactions
時間枠:Up to 5 years

A Cox regression model will be used to evaluate the main effects of treatment arm and the main effect for each stratification factor and the interaction of the stratification factor with treatment in terms of both the primary endpoint and secondary endpoints. The stratification factors to be evaluated include: (1) clinical stage T2 vs. T3/T4a, (2) intended chemotherapy regimen cisplatin vs. 5-FU + mitomycin-C vs. gemcitabine, (3) radiation field small pelvis vs. bladder only and (4) performance status 0-1 vs. 2. There may be other radiation summary measures that may also be explored in terms of their modification of the experimental treatment effect including extent of radiation to lymph node fields. Subgroup analysis defined by stratification factors will also be conducted for primary endpoint and key secondary.

Up to 5 years

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Parminder Singh、SWOG Cancer Research Network

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2019年6月3日

一次修了 (実際)

2026年7月23日

研究の完了 (推定)

2027年11月13日

試験登録日

最初に提出

2018年12月12日

QC基準を満たした最初の提出物

2018年12月12日

最初の投稿 (実際)

2018年12月13日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月18日

QC基準を満たした最後の更新が送信されました

2026年11月17日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • NCI-2018-03264
  • U10CA180888 (米国 NIH グラント/契約)
  • NCI-2018-03264 (レジストリ識別子:CTRP (Clinical Trial Reporting Program))
  • S1806 (その他の識別子:CTEP)
  • S1806 (その他の識別子:SWOG)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

はい

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する